VBIO (Valion Bio, Inc. Common Stock) Stock Analysis - AI Report
Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of May 21, 2026, VBIO trades at $0.85 with a market cap of $2.70M and a P/E ratio of 0.00. VBIO moved +0.00% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.80 to $1.21. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on VBIO?
Rallies AI research for VBIO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
LoConti Joseph E. bought 1.00K (~$200) on Jul 29, 2021.
LoConti Joseph E. bought 13.00K (~$2.60K) on Jul 20, 2021.
LoConti Joseph E. bought 40.00K (~$6.40K) on Jul 19, 2021.
VBIO Analyst Consensus
VBIO analyst coverage data. Average price target: $0.00.
Common questions about VBIO
What is the AI research view on VBIO?
Rallies AI research for VBIO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for VBIO?
Rallies AI research for VBIO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is VBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VBIO. It does not provide personalized investment advice.